SIGN UP
LOG IN
A
ALNY
Alnylam Pharmaceuticals Inc
328.00
2.36+0.72%After Hours: 328.00 0.00 0.00%18:17 07/24 EDT
OPEN/PREV CLOSE326.35/325.64
TODAY RANGE324.30-332.19
VOL677.12K
MARKET CAP42.77B
52 WEEK RANGE205.87-333.70
AVG VOL (3M)936.96K
% TURNOVER0.52%
TURNOVER--
P/E (TTM)-156.7203
% RANGE2.42%
EPS(TTM)-2.0929
P/E(FORWARD)-352.6882
P/B370.29
BVPS0.8858
DIVIDEND--
P/S18.86
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP41.02B
SHARES OUTSTANDING130.39M
NEXT EARNINGS07/30-08/04
FREE FLOAT125.08M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Alnylam’s ALN-TTRSC04: A Promising Phase 1 Study Update
Benzinga·3d ago
This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Dow Jones·3d ago
Alnylam Pharmaceuticals Initiated at Buy by Truist Securities
Reuters·3d ago
U.S. RESEARCH ROUNDUP-Moody's, MSCI, S&P Global
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.